Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

OUTSPOKEN ONCOLOGY

Episode 42: Updates and Controversies in CML With Matt Kalaycio

Matt Kalaycio, MD, Cleveland Clinic, simplifies initial therapy and monitoring decisions for CML, financial implications for patients treated with TKIs, and treatment choices dictated by payers for patients with specific characteristics.

 

Dr Nabhan and Dr Kalaycio have no relevant financial disclosures.

Advertisement

Advertisement

Advertisement